From Science to Investment: How to Evaluate HealthTech Startups
Join LUMUS Investment Collective for a practical evening combining investor education, founder insights and a live startup evaluation.
What you'll learn
How to evaluate HealthTech startups. LUMUS co-founder Terezia Jacova shares a practical framework for assessing healthcare innovation, from scientific evidence and intellectual property to market potential and scalability.
How to turn scientific research into an award-winning brand Meet Lina Rassi, former General Manager at L'Oréal and Shiseido, and Dr. Epameinondas (Epa) Gousopoulos, plastic surgeon and lymphatic researcher, for an honest conversation about building IRÄYE, a Swiss science-backed skincare brand.
How to assess a startup pitch. Lukas Polakovic, CEO of Biomefix, will pitch Biomefix, a novel living synbiotic designed specifically to address the changing gut-microbiome needs of women during the menopause transition. Following a Q&A, we'll evaluate the company together, exchange perspectives and discuss the questions investors should ask before making an investment decision.
Expect practical takeaways, open discussion and the chance to learn from other investors - whether you're already investing or just getting started.
Agenda
17:50 – Doors open
18:00 – Welcome
18:15 – Investor Insights: How to Evaluate HealthTech Startups with Terezia Jacova, LUMUS Co-Founder
18:30 – Fireside chat with Lina Rassi & Dr. Epameinondas Gousopoulos of IRÄYE
19:00 – Live startup pitch by Lukas Polakovic, CEO of Biomefix
19:05 – Q&A and collective investment evaluation
19:30 – Drinks, networking & IRÄYE product experience
Who should come: Angel investors, aspiring angels, and founders who want an honest look at how science becomes a business.
About LUMUS
Europe’s largest female angel investing collective. We believe great investors are made, not born, and we build that confidence through education, community and investing together.